These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 19158846)
1. Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer. Birkholz K; Hombach A; Krug C; Reuter S; Kershaw M; Kämpgen E; Schuler G; Abken H; Schaft N; Dörrie J Gene Ther; 2009 May; 16(5):596-604. PubMed ID: 19158846 [TBL] [Abstract][Full Text] [Related]
2. CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack. Koehler H; Kofler D; Hombach A; Abken H Cancer Res; 2007 Mar; 67(5):2265-73. PubMed ID: 17332357 [TBL] [Abstract][Full Text] [Related]
3. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha. Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961 [TBL] [Abstract][Full Text] [Related]
4. Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression. Huang H; Li F; Gordon JR; Xiang J Cancer Res; 2002 Apr; 62(7):2043-51. PubMed ID: 11929823 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous generation of CD8+ and CD4+ melanoma-reactive T cells by retroviral-mediated transfer of a single T-cell receptor. Roszkowski JJ; Lyons GE; Kast WM; Yee C; Van Besien K; Nishimura MI Cancer Res; 2005 Feb; 65(4):1570-6. PubMed ID: 15735047 [TBL] [Abstract][Full Text] [Related]
6. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Martinotti A; Stoppacciaro A; Vagliani M; Melani C; Spreafico F; Wysocka M; Parmiani G; Trinchieri G; Colombo MP Eur J Immunol; 1995 Jan; 25(1):137-46. PubMed ID: 7843224 [TBL] [Abstract][Full Text] [Related]
7. Targeting of T cells to CEA-expressing tumor cells by chimeric immune receptors with a highly specific single-chain anti-CEA activity. Arakawa F; Shibaguchi H; Xu Z; Kuroki M Anticancer Res; 2002; 22(6C):4285-9. PubMed ID: 12553071 [TBL] [Abstract][Full Text] [Related]
8. Human gammadelta T cells as mediators of chimaeric-receptor redirected anti-tumour immunity. Rischer M; Pscherer S; Duwe S; Vormoor J; Jürgens H; Rossig C Br J Haematol; 2004 Aug; 126(4):583-92. PubMed ID: 15287953 [TBL] [Abstract][Full Text] [Related]
9. Rapid alphabeta TCR-mediated responses in gammadelta T cells transduced with cancer-specific TCR genes. Hiasa A; Nishikawa H; Hirayama M; Kitano S; Okamoto S; Chono H; Yu SS; Mineno J; Tanaka Y; Minato N; Kato I; Shiku H Gene Ther; 2009 May; 16(5):620-8. PubMed ID: 19242528 [TBL] [Abstract][Full Text] [Related]
10. Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells. Moeller M; Kershaw MH; Cameron R; Westwood JA; Trapani JA; Smyth MJ; Darcy PK Cancer Res; 2007 Dec; 67(23):11428-37. PubMed ID: 18056471 [TBL] [Abstract][Full Text] [Related]
11. Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model. Yoon SH; Lee JM; Cho HI; Kim EK; Kim HS; Park MY; Kim TG Cancer Gene Ther; 2009 Jun; 16(6):489-97. PubMed ID: 19096447 [TBL] [Abstract][Full Text] [Related]
12. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy. Chen HW; Liao CH; Ying C; Chang CJ; Lin CM Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844 [TBL] [Abstract][Full Text] [Related]
13. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo. Chen W; Schweins E; Chen X; Finn OJ; Cheever MA J Immunol; 1994 Oct; 153(8):3630-8. PubMed ID: 7930583 [TBL] [Abstract][Full Text] [Related]
14. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
15. Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2. Yamaguchi Y; Ohta K; Shimizu K; Minami K; Noma K; Hihara J; Toge T Anticancer Res; 2001; 21(1B):669-77. PubMed ID: 11299824 [TBL] [Abstract][Full Text] [Related]
16. Genetic engineering of cytolytic T lymphocytes for adoptive T-cell therapy of neuroblastoma. Gonzalez S; Naranjo A; Serrano LM; Chang WC; Wright CL; Jensen MC J Gene Med; 2004 Jun; 6(6):704-11. PubMed ID: 15170741 [TBL] [Abstract][Full Text] [Related]
17. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. Weijtens ME; Willemsen RA; Hart EH; Bolhuis RL Gene Ther; 1998 Sep; 5(9):1195-203. PubMed ID: 9930320 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells. Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807 [TBL] [Abstract][Full Text] [Related]
19. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy. Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874 [TBL] [Abstract][Full Text] [Related]
20. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro. Cao DY; Yang JY; Dou KF; Ma LY; Teng ZH Hum Immunol; 2007 May; 68(5):334-41. PubMed ID: 17462500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]